Details for New Drug Application (NDA): 077307
✉ Email this page to a colleague
The generic ingredient in TRANDOLAPRIL is trandolapril; verapamil hydrochloride. There are ten drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the trandolapril; verapamil hydrochloride profile page.
Summary for 077307
Tradename: | TRANDOLAPRIL |
Applicant: | Chartwell Molecular |
Ingredient: | trandolapril |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
Approval Date: | Jun 12, 2007 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
Approval Date: | Jun 12, 2007 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 4MG | ||||
Approval Date: | Jun 12, 2007 | TE: | RLD: | No |
Complete Access Available with Subscription